PRKAA1 and cancer: In 2008 it was reported that AMPK was activated in response to the anti-cancer agent etoposide [76], and this was later also observed on treatment of cells with hydroxyurea, aphidicolin, bleomycin or ultraviolet light [8], as well as ionizing radiation [77].